The HRS9531-201 clinical trial was a multi-centre, randomised, double-blind, placebo-parallel controlled Phase 2 clinical study (NCT05881837) conducted by Hengrui Pharma in China to evaluate the efficacy and safety of HRS9531 injection in adults (aged 18-65) with obesity (BMI of 2840 kg/m2) without type 2 diabetes
Generally, it entails months of medical and behavioral preparation, including a mental health assessment, explains Evan Nadler, MD, an adjunct associate professor at the George Washington University School of Medicine and Health Sciences in Washington, D.C., who has performed hundreds of pediatric bariatric surgeries
5.2 Safety evaluation In both clinical trials and real-world settings, tirzepatide has demonstrated a favorable safety and tolerability profile
It may mean the body has adapted to a lower weight, calorie needs have changed, muscle preservation needs more attention, constipation or fluid shifts are masking progress, or the plan needs to be adjusted for the next phase of treatment
Hers offers various weight loss options, including oral medications, injections like Ozempic and Wegovy, and compounded GLP-1s
Aminian A, Zajichek A, Arterburn DE, et al
